Pancreatic Cancer Research

ResearcherGeneral Hospital of Shenyang Military RegionNo recent work listed

Xingshun Qi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9448-6739; OpenAlex author ID A5006822581. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD82 Cell Line. Co-author DOI 10.1177/15330338211045204↗
  2. Portal Hypertension in a Patient With Recurrent Pancreatic Cancer After Radiotherapy and Systemic Chemotherapy. Co-author DOI 10.1016/j.jceh.2017.11.005↗
  3. Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer. Last author DOI 10.3892/mmr.2016.5093↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongyu Li · 3 shared papers, 2016–2021 · strength 0.33
  2. Xiaozhong Guo · 2 shared papers, 2016–2018 · strength 0.17
  3. Shuo Wang · 1 shared paper, 2021 · strength 0.16
  4. Xiaozhong Guo · 1 shared paper, 2021 · strength 0.16
  5. Chen Jiang · 1 shared paper, 2021 · strength 0.16
  6. Xu Liu · 1 shared paper, 2021 · strength 0.16
  7. Xiaodong Shao · 1 shared paper, 2018 · strength 0.10
  8. Xu Liu · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.